Mercury Bio, Inc.

BiotechnologyB2BBiotechnologyDrug Delivery

📍 Santa Fe, New Mexico, United States• Founded 2021

StreetZero Signal 73

Be the first to signal interest

About Mercury Bio, Inc.

Mercury Bio, Inc. is a Santa Fe, New Mexico-based privately held biotechnology company founded in 2021. It develops a next-generation biomolecular drug delivery platform using natural vesicles for targeted molecular delivery, with a focus on intracellular therapies for neurodegenerative diseases such as Parkinson's and Alzheimer's. The company operates a B2B business model in biotechnology research and has launched candidates toward FDA IND approval while building an IP portfolio and institutional collaborations.

LATEST FUNDINGPrivate Placement

$1.6M

Announced 2026-11-13

TOTAL RAISED$5.76M

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for Mercury Bio, Inc..

Create free account Sign in

Free plan includes 3 full deal profiles every month.

IN THE NEWS

EMPLOYEES—

FOUNDED2021

HQSanta Fe, New Mexico, United States

Industry

Biotechnology

Investors

Los Alamos National Laboratory New Mexico Consortium New Mexico Economic Development Department

Key highlights

Closed $2M seed round in August 2023 and appointed a Finance Director.
Total funding across six rounds exceeds $5.76M with support from New Mexico research institutions.
Developing MB-TIP platform for intracellular targeting in immunotherapy and neurodegenerative diseases.
Advancing lead candidates for Parkinson's and Alzheimer's toward FDA IND approval.